JOHNSON DAVID LEE 4
4 · Vera Therapeutics, Inc. · Filed Jul 3, 2024
Insider Transaction Report
Form 4
JOHNSON DAVID LEE
Chief Operating Officer
Transactions
- Award
Stock Option (right to buy)
2024-07-01+160,000→ 160,000 totalExercise: $36.29Exp: 2034-06-30→ Class A Common Stock (160,000 underlying)
Footnotes (1)
- [F1]1/4 of the shares subject to the option vest on July 1, 2025, and 1/48 of the shares vest monthly thereafter, subject to continuous service of the Reporting Person through each vesting date.